Giselle Hevia Hernández

Title: Innovations of Giselle Hevia Hernández

Introduction

Giselle Hevia Hernández is a prominent inventor based in Havana, Cuba. She has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic agents. Her work focuses on the creation of fusion proteins that have the potential to revolutionize cancer treatment.

Latest Patents

Giselle holds a patent for her invention titled "Fusion proteins composed of an interleukin-2 mutein and type I interferon." This patent describes bi-cytokines, which are fusion proteins formed by the binding of an IL2 agonist mutein with a type I interferon. These proteins are linked by an Fc region of a mutant human IgG1 and a connector peptide. The innovative combination of these components provides surprising immunoregulatory properties and superior therapeutic effects compared to traditional cytokines. This makes her invention a promising candidate for cancer treatment. The patent also includes pharmaceutical compositions that utilize these fusion proteins as active ingredients.

Career Highlights

Giselle is affiliated with the Centro de Inmunología Molecular, where she conducts her research and development activities. Her work has garnered attention for its potential impact on cancer therapies. She has successfully navigated the complexities of patenting her innovations, ensuring that her contributions to science are recognized and protected.

Collaborations

Giselle collaborates with notable colleagues, including Tays Hernández García and Maura Lisett Rábade Chediak. These partnerships enhance her research efforts and contribute to the advancement of their shared goals in biotechnology.

Conclusion

Giselle Hevia Hernández is an influential inventor whose work in fusion proteins holds great promise for the future of cancer treatment. Her innovative approach and dedication to research exemplify the spirit of scientific advancement.